File
| Title | Disorder | Modality | PI/Lead Investigator | Institution |
|---|---|---|---|---|
| Development of anti-LTBP4 as a biologic to treat Neuromuscular Diseases | Duchenne Muscular Dystrophy | Monoclonal antibody | Alexis Demonbreun | Northwestern University at Chicago |
| Preclinical and Early Clinical Development of a Novel Drug for On-Demand Voiding | Spinal cord injury | Peptide | Edward Burgard | Dignify Therapeutics, LLC |
| Development of Utrophin Site Blocking Oligos (SBOs) to treat Duchenne Muscular Dystrophy (DMD) | Duchenne Muscular Dystrophy | Site blocking oligonuclotide | Tejvir S. Khurana | University of Pennsylvania |
| Development of AAV-AIBP for neuroprotecction in glaucoma | Glaucoma | AAV-encoding protein | Wonkyu Ju | University of California- San Diego |
BPN-Biologics Staff
Program Director
Dr. Chris Boshoff
Health Program Specialists
Ms. Shruthi ThomasOperations Coordinator
Ms. Natasha DavisEOC Board Manager
Ms. Oreisa O'Neil-Mathurin